{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:15:15Z","timestamp":1753892115751,"version":"3.41.2"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T00:00:00Z","timestamp":1645747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Protamine can decrease the risk of hemorrhage during carotid recanalization. However, it may cause severe side effects. There is no consensus on the safety and efficacy of protamine during surgery. Thus, we conduct a comprehensive review and meta-analysis to compare the differences between the protamine and the no-protamine group.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> We systematically obtained literature from Medline, Google Scholar, Cochrane Library, and PubMed electronic databases. All four databases were scanned from 1937 when protamine was first adopted as a heparin antagonist until February 2021. The reference lists of identified studies were manually checked to determine other eligible studies that qualify. The articles were included in this meta-analysis as long as they met the criteria of PICOS; conference or commentary articles, letters, case report or series, and animal observation were excluded from this study. The Newcastle-Ottawa Quality Assessment Scale and Cochrane Collaboration\u2019s tool are used to assess the risk of bias of each included observational study and RCT, respectively. Stata version 12.0 statistical software (StataCorp LP, College Station, Texas) was adopted as statistical software. When <jats:italic>I<\/jats:italic><jats:sup>2<\/jats:sup> &amp;lt; 50%, we consider that the data have no obvious heterogeneity, and we conduct a meta-analysis using the fixed-effect model. Otherwise, the random-effect model was performed.<\/jats:p><jats:p><jats:bold>Result:<\/jats:bold> A total of 11 studies, consisting of 94,618 participants, are included in this study. Our analysis found that the rate of wound hematoma had a significant difference among protamine and no-protamine patients (OR = 0.268, 95% CI = 0.093 to 0.774, <jats:italic>p<\/jats:italic> = 0.015). Furthermore, the incidence of hematoma requiring re-operation (0.7%) was significantly lower than that of patients without protamine (1.8%). However, there was no significant difference in the incidence of stroke, wound hematoma with hypertension, transient ischemic attacks (TIA), myocardial infarction (MI), and death.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> Among included participants undergoing recanalization, the use of protamine is effective in reducing hematoma without increasing the risk of having other complications. Besides, more evidence-based performance is needed to supplement this opinion due to inherent limitations.<\/jats:p>","DOI":"10.3389\/fphar.2022.796329","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T09:39:10Z","timestamp":1645781950000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["A Meta-Analysis of Using Protamine for Reducing the Risk of Hemorrhage During Carotid Recanalization: Direct Comparisons of Post-operative Complications"],"prefix":"10.3389","volume":"13","author":[{"given":"Yongli","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqiang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingzheng","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Xin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"3288","DOI":"10.1161\/STROKEAHA.115.003390","article-title":"Systematic Review of Guidelines for the Management of Asymptomatic and Symptomatic Carotid Stenosis","volume":"46","author":"Abbott","year":"2015","journal-title":"Stroke"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.jcin.2020.03.041","article-title":"Safety and Efficacy of Protamine Administration for Prevention of Bleeding Complications in Patients Undergoing TAVR","volume":"13","author":"Al-Kassou","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1111\/jth.13405","article-title":"Protamine (Heparin)-induced Thrombocytopenia: a Review of the Serological and Clinical Features Associated with Anti-protamine\/heparin Antibodies","volume":"14","author":"Bakchoul","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"B4","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.bja.2018.01.023","article-title":"Anticoagulant and Side-Effects of Protamine in Cardiac Surgery: a Narrative Review","volume":"120","author":"Boer","year":"2018","journal-title":"Br. J. Anaesth."},{"key":"B5","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00234-011-0950-3","article-title":"Early Recurrent Hemorrhage after Coil Embolization in Ruptured Intracranial Aneurysms","volume":"54","author":"Cho","year":"2012","journal-title":"Neuroradiology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.ejvs.2008.01.021","article-title":"Is Heparin Reversal with Protamine after Carotid Endarterectomy Dangerous?","volume":"36","author":"Dellagrammaticas","year":"2008","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"B7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11910-017-0786-2","article-title":"Carotid Artery Stenosis: Medical Therapy, Surgery, and Stenting","volume":"17","author":"Dharmakidari","year":"2017","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/s1078-5884(97)80082-2","article-title":"Should Heparin Be Reversed after Carotid Endarterectomy? A Randomised Prospective Trial","volume":"13","author":"Fearn","year":"1997","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"B9","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1093\/bja\/aem137","article-title":"Carotid Endarterectomy","volume":"99","author":"Howell","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"B10","first-page":"1291","article-title":"Protamine--antagonist to Heparin","volume":"108","author":"Jaques","year":"1973","journal-title":"Can. Med. Assoc. J."},{"key":"B11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.ejvs.2016.05.033","article-title":"Protamine Reduces Bleeding Complications without Increasing the Risk of Stroke after Carotid Endarterectomy: A Meta-Analysis","volume":"52","author":"Kakisis","year":"2016","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"B12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/ane.13062","article-title":"Carotid Artery Stenting: Current State of Evidence and Future Directions","volume":"139","author":"Lamanna","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"B13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s100169900222","article-title":"Relationship of Protamine Dosing with Postoperative Complications of Carotid Endarterectomy","volume":"13","author":"Levison","year":"1999","journal-title":"Ann. Vasc. Surg."},{"key":"B14","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.wneu.2019.04.062","article-title":"Meta-Analysis of Prognosis of Different Treatments for Symptomatic Moyamoya Disease","volume":"127","author":"Li","year":"2019","journal-title":"World Neurosurg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jvs.2020.04.526","article-title":"Protamine Use in Transfemoral Carotid Artery Stenting Is Not Associated with an Increased Risk of Thromboembolic Events","volume":"73","author":"Liang","year":"2021","journal-title":"J. Vasc. Surg."},{"key":"B16","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.jvs.2020.02.019","article-title":"Protamine Use in Transcarotid Artery Revascularization Is Associated with Lower Risk of Bleeding Complications without Higher Risk of Thromboembolic Events","volume":"72","author":"Liang","year":"2020","journal-title":"J. Vasc. Surg."},{"key":"B17","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ejvs.2015.09.001","article-title":"Does Routine Reversal of Heparin with Protamine Sulphate in Patients Undergoing Carotid Endarterectomy Reduce Bleeding Complications without Leading to Increased Thromboembolic Complications?","volume":"51","author":"Lynch","year":"2016","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"B18","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/s0741-5214(95)70140-0","article-title":"Stroke Rate Is Markedly Reduced after Carotid Endarterectomy by Avoidance of Protamine","volume":"22","author":"Mauney","year":"1995","journal-title":"J. Vasc. Surg."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s00268-013-2347-4","article-title":"Using Protamine Can Significantly Reduce the Incidence of Bleeding Complications after Carotid Endarterectomy without Increasing the Risk of Ischemic Cerebral Events","volume":"38","author":"Mazzalai","year":"2014","journal-title":"World J. Surg."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1161\/STROKEAHA.113.001188","article-title":"Protamine Does Not Increase Risk of Stroke in Patients with Elective Carotid Stenting","volume":"44","author":"McDonald","year":"2013","journal-title":"Stroke"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/md17090539","article-title":"The Inhibitory Effect of Protamine on Platelets Is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents","volume":"17","author":"Miklosz","year":"2019","journal-title":"Mar. Drugs"},{"key":"B22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/1471-0528.14180","article-title":"Psychological Morbidity Associated with Hyperemesis Gravidarum: a Systematic Review and Meta-Analysis","volume":"124","author":"Mitchell-Jones","year":"2017","journal-title":"BJOG"},{"key":"B23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1001\/jamasurg.2015.3592","article-title":"Use of Protamine for Anticoagulation during Carotid Endarterectomy: A Meta-Analysis","volume":"151","author":"Newhall","year":"2016","journal-title":"JAMA Surg."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.jvs.2013.06.064","article-title":"Shared Quality Data Are Associated with Increased Protamine Use and Reduced Bleeding Complications after Carotid Endarterectomy in the Vascular Study Group of New England","volume":"58","author":"Patel","year":"2013","journal-title":"J. Vasc. Surg."},{"key":"B25","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1177\/1708538120924149","article-title":"Protamine Sulfate Use during Tibial Bypass Does Not Appear to Increase Thrombotic Events or Affect Short-Term Graft Patency","volume":"28","author":"Phair","year":"2020","journal-title":"Vascular"},{"key":"B26","doi-asserted-by":"publisher","first-page":"CD001081","DOI":"10.1002\/14651858.CD001081.pub4","article-title":"Carotid Endarterectomy for Symptomatic Carotid Stenosis","volume":"9","author":"Rerkasem","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1053\/j.semvascsurg.2018.03.001","article-title":"Introduction: Carotid Endarterectomy versus Carotid Stenting-A Never-Ending story","volume":"31","author":"Setacci","year":"2018","journal-title":"Semin. Vasc. Surg."},{"key":"B28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1080\/17425255.2016.1194395","article-title":"The Toxicology of Heparin Reversal with Protamine: Past, Present and Future","volume":"12","author":"Sokolowska","year":"2016","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1136\/svn-2016-000016","article-title":"Appropriate Management of Asymptomatic Carotid Stenosis","volume":"1","author":"Spence","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/HCO.0000000000000679","article-title":"Carotid Artery Stenting: an Update","volume":"34","author":"Spiliopoulos","year":"2019","journal-title":"Curr. Opin. Cardiol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ejvs.2020.08.047","article-title":"Protamine Reduces Serious Bleeding Complications Associated with Carotid Endarterectomy in Asymptomatic Patients without Increasing the Risk of Stroke, Myocardial Infarction, or Death in a Large National AnalysisStroke, Myocardial Infarction, or Death in a Large National Analysis","volume":"60","author":"Stone","year":"2020","journal-title":"Eur. J. Vasc. Endovasc Surg."},{"key":"B32","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jvs.2009.10.078","article-title":"Protamine Reduces Bleeding Complications Associated with Carotid Endarterectomy without Increasing the Risk of Stroke","volume":"51","author":"Stone","year":"2010","journal-title":"J. Vasc. Surg."},{"key":"B33","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/0741-5214(90)90046-d","article-title":"The Influence of Neutralizing Heparin after Carotid Endarterectomy on Postoperative Stroke and Wound Hematoma","volume":"12","author":"Treiman","year":"1990","journal-title":"J. Vasc. Surg."},{"key":"B34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ijcard.2016.03.172","article-title":"Carotid Stenting and Endarterectomy","volume":"214","author":"Yip","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1536\/ihj.17-312","article-title":"Carotid Artery Stenting versus Carotid Endarterectomy for Treatment of Asymptomatic Carotid Artery Stenosis","volume":"59","author":"Yuan","year":"2018","journal-title":"Int. Heart J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fneur.2019.00719","article-title":"Cerebral Hemodynamic Evaluation after Cerebral Recanalization Therapy for Acute Ischemic Stroke","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Neurol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.796329\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T09:39:12Z","timestamp":1645781952000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.796329\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,25]]},"references-count":36,"alternative-id":["10.3389\/fphar.2022.796329"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.796329","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2022,2,25]]},"article-number":"796329"}}